6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one

6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one Suppliers list
Company Name: Zhengzhou Granlen Sciences, ltd.  
Tel: 0371-85513397 +86-18610099868
Email: info@granlen.com
Company Name: NewCan Biotech Limited  
Tel: +86-571-86912261 19975279805
Email: sales@newcanbio.com
Company Name: BOC Sciences  
Tel: 16314854226
Email: inquiry@bocsci.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai meikai technology co., ltd  
Tel: 021-68689288 15300790979
Email: info@mkbio.com.cn

6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one manufacturers

6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one Basic information
Product Name:6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
Synonyms:6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one;6-Amino-2,5-dihydro-2-(beta-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one;6-Amino-2,5-dihydro-2-(b-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one;4H-Pyrazolo[3,4-d]pyrimidin-4-one, 6-amino-1,2-dihydro-2-β-D-ribofuranosyl-;6-amino-2-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one;6-Amino-2,5-dihydro-2-(β-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
CAS:85426-86-4
MF:C10H13N5O5
MW:283.24072
EINECS:
Product Categories:
Mol File:85426-86-4.mol
6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one Structure
6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one Chemical Properties
density 2.25±0.1 g/cm3(Predicted)
pka7.99±0.20(Predicted)
Safety Information
MSDS Information
6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one Usage And Synthesis
Uses6-Amino-1,2-dihydro-2-β-D-ribofuranosyl-4H-pyrazolo[3,4-d]pyrimidin-4-one is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one Preparation Products And Raw materials
Tag:6-Amino-2,5-dihydro-2-(-D-ribofuranosyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one(85426-86-4) Related Product Information
6-aminoallopurinol riboside 5-Chloro-2'-deoxyuridine Capecitabine 6-Mercaptopurine Clofarabine Broxuridine